VolitionRX Ltd. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
-
14.80
-
-
-
639.90
Cost of Goods Sold (COGS) incl. D&A
146.40
142.10
236.30
309.40
542.50
639.90
Gross Income
146.40
127.30
236.30
309.40
542.50
639.90
SG&A Expense
4,079.50
5,810.10
9,769.40
11,957.20
14,503.40
17,257.80
EBIT
4,225.90
5,937.40
10,005.70
12,266.60
15,045.90
17,897.70
Unusual Expense
350.00
2,420.10
339.70
-
-
-
Non Operating Income/Expense
-
-
15.70
-
349.80
-
Interest Expense
-
-
-
-
73.10
110.90
Pretax Income
3,710.30
8,213.50
9,534.80
11,905.30
14,769.20
18,008.60
Income Tax
-
-
4.60
-
-
-
Consolidated Net Income
3,710.30
8,213.50
9,530.20
11,905.30
14,769.20
18,008.60
Net Income
3,710.30
8,213.50
9,530.20
11,905.30
14,769.20
18,008.60
Net Income After Extraordinaries
3,710.30
8,213.50
9,530.20
11,905.30
14,769.20
18,008.60
Net Income Available to Common
3,710.30
8,213.50
9,530.20
11,905.30
14,769.20
18,008.60
EPS (Basic)
0.34
0.61
0.54
0.52
0.56
0.57
Basic Shares Outstanding
10,832.40
13,435.30
17,731.80
23,049.10
26,389.60
31,389.20
EPS (Diluted)
0.34
0.61
0.54
0.52
0.56
0.57
Diluted Shares Outstanding
10,832.40
13,435.30
17,731.80
23,049.10
26,389.60
31,389.20
EBITDA
4,079.50
5,795.30
9,769.40
11,957.20
14,503.40
17,257.80

About VolitionRX

View Profile
Address
1 Scotts Road
Singapore CE 228208
Singapore
Employees -
Website http://www.volitionrx.com
Updated 07/08/2019
VolitionRX Ltd. is a multi-national life sciences company, which engages in the development of blood-based cancer tests to help diagnose a range of cancers. Its products include the Nucleosomics platform that identifies and measures nucleosomes in the bloodstream or other bodily fluid. The company was founded on August 5, 2010 and is headquartered in Singapore.